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Midlife and Late-Life Vascular Risk Factors and White Matter
Microstructural Integrity: The Atherosclerosis Risk in Communities
Neurocognitive Study
Melinda C. Power, ScD; Jonathan V. Tingle, BA; Robert I. Reid, PhD; Juebin Huang, MD; A. Richey Sharrett, MD; Josef Coresh, MD;
Michael Griswold, PhD; Kejal Kantarci, MD, MS; Clifford R. Jack, Jr, MD; David Knopman, MD; Rebecca F. Gottesman, MD;
Thomas H. Mosley, PhD

Background-—Diffusion tensor imaging measures of white matter (WM) microstructural integrity appear to provide earlier
indication of WM injury than WM hyperintensities; however, risk factors for poor WM microstructural integrity have not been
established. Our study quantiﬁes the association between vascular risk factors in midlife and late life with measures of late-life WM
microstructural integrity.

Downloaded from http://jaha.ahajournals.org/ by guest on May 24, 2017

Methods and Results-—We used data from 1851 participants in ARIC (Atherosclerosis Risk in Communities Study) who completed
3-T magnetic resonance imaging, including diffusion tensor imaging, as part of the ARIC Neurocognitive Study (ARIC-NCS). We
quantiﬁed the association among lipids, glucose, and blood pressure from the baseline ARIC visit (1987–1989, ages 44–65,
midlife) and visit 5 of ARIC (2011–2013, ages 67–90, late life, concurrent with ARIC-NCS) with regional and overall WM mean
diffusivity and fractional anisotropy obtained at ARIC visit 5 for ARIC participants. We also considered whether these associations
were independent of or modiﬁed by WM hyperintensity volumes. We found that elevated blood pressure in midlife and late life and
elevated glucose in midlife, but not late life, were associated with worse late-life WM microstructural integrity. These associations
were independent of the degree of WM hyperintensity, and the association between glucose and WM microstructural integrity
appeared stronger for those with the least WM hyperintensity. There was little support for an adverse association between lipids
and WM microstructural integrity.
Conclusions-—Hypertension in both midlife and late life and elevated glucose in midlife are related to worse WM microstructural
integrity in late life. ( J Am Heart Assoc. 2017;6:e005608. DOI: 10.1161/JAHA.117.005608.)
Key Words: blood pressure • epidemiology • leukoencephalopathy • risk factor • type 2 diabetes mellitus

V

ascular risk factors may increase the risk of subsequent
cognitive decline and dementia, with the strongest
evidence supporting a link between midlife vascular risk-factor
levels and late life cognition.1–3 In the absence of stroke,
subclinical brain injury likely mediates these associations.
Diffusion tensor imaging (DTI) quantiﬁes the microstructural
integrity of white matter (WM),4 which almost certainly plays a

role in later life cognitive impairment,5,6 and so can be used to
assess subclinical brain injury. DTI also complements other
neuroimaging measures, namely measures of WM hyperintensities (WMHs) or WM volumes, because it provides an
assessment of pathologic changes that precede and predict
the development of WMH or WM loss.7–12 Consequently,
changes to WM microstructural integrity provide an early
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What Is New?
• Diffusion tensor imaging quantiﬁes the microstructural
integrity of white matter in the brain.
• Changes to brain white matter microstructural integrity
provide an early indication of who is at risk of cerebral white
matter injury and subsequent cognitive impairment.
• We found elevated glucose in midlife and elevated blood
pressure at both midlife and late life were associated with
worse brain white matter microstructural integrity. These
associations were largely independent of the severity of
white matter hyperintensities, a marker of cerebral white
matter injury.
• Lipid levels at midlife or late life were not associated with
brain white matter microstructural integrity.

What Are the Clinical Implications?
Downloaded from http://jaha.ahajournals.org/ by guest on May 24, 2017

• Avoiding elevated glucose in midlife and hypertension at any
point may prevent later damage to brain white matter
microstructural integrity and its downstream effects.
• Diffusion tensor imaging–based measures may be appropriate risk-stratiﬁcation tools or surrogate outcomes in clinical
trials intervening with regard to vascular risk factors.
• Additional work is required to conﬁrm these ﬁndings and to
better establish the utility of these markers.

indication of who is at risk of cerebral WM injury, including both
WMH and WM loss, and subsequent cognitive impairment.
Identifying risk factors for poor WM microstructural integrity
will help us understand the extent to which DTI-based measures
are appropriate risk-stratiﬁcation tools or surrogate outcomes
in clinical trials. As such, understanding risk factors for poor WM
microstructural integrity will be critical in efforts to prevent or
mitigate these adverse outcomes.
Given the link between measures of WM microstructural
integrity and subsequent development of WMHs, we hypothesized that risk factors for poor WM microstructural integrity
and WMHs would be similar. Elevated blood pressure is
consistently associated with the presence, severity, and
progression of WMH, regardless of the timing of measurement.13–18 Although diabetes mellitus and fasting glucose are
not typically associated with WMH in cross-sectional analyses,19,20 previous diabetes mellitus and fasting glucose are
related to WMH progression and later WMH severity in
longitudinal analyses.16,18 Conversely, lipids do not appear to
be associated with severity or progression of WMH.16,19 In
comparison, existing studies evaluating the association
between these risk factors and WM microstructural integrity
are typically small and cross-sectional, and despite evidence of
a link between WM microstructural integrity and WMH, most
have not investigated whether the association is independent
DOI: 10.1161/JAHA.117.005608

of or modiﬁed by WMH. The goal of this study was to quantify
the association of midlife and late-life measures of vascular risk
factors with late-life WM microstructural integrity in a relatively
large sample of persons drawn from ARIC-NCS (Atherosclerosis Risk in Communities Neurocognitive Study) and to consider
whether the association is independent of or modiﬁed by WMH.

Methods
Study Population
The ARIC study is a longitudinal cohort study of 15 792
persons recruited between 1987 and 1989 (visit 1) from 4 US
communities: suburbs of Minneapolis, Minnesota; Forsyth
County, North Carolina; Washington County, Maryland; and
Jackson, Mississippi. In 2011–2013 (visit 5), all persons with
evidence of cognitive impairment and a stratiﬁed random
sample of other participants were invited to complete brain
magnetic resonance imaging (MRI) as part of ARIC-NCS.21 As
such, although the MRI subsample is enriched with persons
with cognitive impairment, use of derived sampling weights
allows estimation of what the effects would be had we obtained
MRI on all ARIC visit 5 participants. Our eligible sample
included those ARIC-NCS participants with valid DTI data,
excluding nonblack and nonwhite persons (n=6), black participants from Maryland or Minnesota (n=9), persons disallowing
the use of genetic data (n=10), and persons with prior stroke
(n=66). Primary analyses also excluded persons missing
exposure or covariate data; we considered associations in
the full eligible sample after multiply imputing missing data in
sensitivity analyses. The institutional review boards of all
participating institutions approved this study, and participants
provided written informed consent before participation.

Brain Imaging
At ARIC-NCS, each study site followed identical protocols for
3-T brain MRI. All scans included sagittal T1-weighted MPRAGE
(magnetization-prepared rapid gradient-echo imaging), axial T2
FLAIR (ﬂuid attenuation inversion recovery), and axial DTI pulse
sequences. Data were processed by the ARIC MRI Reading
Center at the Mayo Clinic (Rochester, MN). We provide an
overview below (see Supplementary Methods for details).
Fractional anisotropy (FA) measures the directional constraint of water diffusion and ranges from 0 to 1 (unitless).
Mean diffusivity (MD) is a scalar measure of how quickly water
molecules diffuse overall (mm2/s). Lower FA and higher MD
indicate worse WM microstructural integrity. WM FA and MD
were calculated for brain regions deﬁned by an in-house atlas
of lobar and deep WM regions based on the STAND400
template.22 The WM regions were intersected with tissue
segmentations from each participant’s T1-weighted and FLAIR
Journal of the American Heart Association
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Vascular Risk Factors
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We considered vascular risk factors at ARIC visit 1 (1987–
1989, midlife, ages 44–65) and ARIC visit 5 (2011–2013, late
life, ages 67–90). Plasma total cholesterol and triglycerides
were measured using enzymatic methods,25,26 high-density
lipoprotein cholesterol (HDL-C) concentrations were determined after precipitation of non-HDL lipoproteins,27,28 and
low-density lipoprotein cholesterol (LDL-C) levels were calculated using the Friedewald equation.29 Serum glucose was
measured using the hexokinase method.30 Systolic blood
pressure (SBP) and diastolic blood pressure (DBP) were
measured 3 times according to a standard protocol; we
consider the mean of the 2 ﬁnal measurements.

Covariates
All covariates are based on data collected at ARIC visit 1 or at
ARIC visit 5 and include age (years), sex (male, female), race
and center (black–Mississippi, black–North Carolina, white–
North Carolina, white–Maryland, white–Minnesota), education
(less than high school/high school, General Educational
Development test, vocational school, some college/college,
graduate or professional school), APOE*E4 allele status
(present, absent), body mass index (kg/m2), smoking status
(current, former, never), antihypertensive medication use (yes,
no), lipid-lowering medication use (yes, no), and diabetes
mellitus medication use (yes, no). Medication use was
determined through direct visual inspection and linkage to
Medi-Span therapeutic classiﬁcation codes.

vascular risk factor and WM FA and MD in each ROI. The
weights account for the approach used to select ARIC
participants for MRI. Given slight deviations from a linear
dose-response pattern for some exposures in exploratory
analyses, we considered associations with both categorical
and linear exposure parameterizations. All analyses were
adjusted for the covariates described above and the other
vascular risk factors (eg, SBP, DBP, and glucose in models
estimating associations with lipids). Time-varying covariates
were updated to reﬂect the status at the time of exposure
assessment (eg, visit 1 age when considering visit 1 SBP, visit
5 age for visit 5 SBP). We then adjusted these primary models
for total WMH volumes and intracranial volume to determine
whether our associations were independent of WMH severity.
We conducted several sensitivity analyses. We repeated
analyses considering glucose and lipids after restricting those
who were fasting ≥8 hours at blood draw (98% at visit 1, 96%
at visit 5). We repeated analyses for glucose and blood
pressure adjusting for total cholesterol, HDL-C, and triglycerides rather than LDL-C. We restricted analyses of triglycerides to those with <500 mg/dL triglycerides to exclude
potentially inﬂuential outliers. We considered analyses after
multiply imputing missing exposure and covariate data31 to
understand the inﬂuence and missing data. Finally, we
considered unweighted analyses to understand the inﬂuence
of the selection process by which we selected visit 5
participants for MRI and analyses additionally weighted with
inverse probability of attrition weights32,33 to better understand the potential inﬂuence of potentially informative
attrition from visit 1 to visit 5 on our results.
We used multiplicative interaction terms to evaluate effect
modiﬁcation by age (<75 or ≥75 years), race (black or white),
sex (male or female), APOE*E4 (present or absent), cognitive
status (normal/mild cognitive impairment or dementia), and
WMH severity (deciles of intracranial volume-standardized
WMH volumes). We considered P<0.05 to be statistically
signiﬁcant and reported 95% conﬁdence intervals. We did not
adjust for multiple comparisons, given that the association
between a vascular risk factor at a given time point and 1
measure of WM microstructural integrity is likely correlated
with associations considering other time points or ROIs. All
analyses were completed using SAS version 9.4, STATA
version 14.0, or R version 3.1.2.

Results
Statistical Methods
We standardized ROI WM FA and MD by subtracting the
sample mean and dividing by the sample standard deviation.
For our primary analyses, we used separate weighted linear
regression models to quantify the association between each

DOI: 10.1161/JAHA.117.005608

Weighted characteristics of the 1851 eligible persons are
provided in Table. Mean SBP and glucose were higher at visit
5 than at visit 1, whereas mean DBP, total cholesterol, and
LDL-C were lower. Tables S1 and S2 provide unweighted
summary statistics and information on missingness.
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images; WM FA and MD were calculated using voxels with a
>50% probability of being WM. The segmentation takes care
to include WMHs as WM. To account for imperfect registration
between the DTI and T1-weighted images, an upper cutoff of
MD <0.002 mm2/s was applied to exclude edge voxels that
were primarily cerebrospinal ﬂuid. We averaged left and right
WM FA and MD across atlas regions and then took a weighted
average, with weights based on the number of voxels in each
WM region, to create WM FA and MD measures for 7 regions
of interest (ROIs): frontal, temporal, occipital, and parietal
lobes; anterior and posterior corpus callosum; and an overall
measure—the weighted average of these 6 ROIs (capsular
WM was not included). WMH and intracranial volumes were
quantiﬁed via in-house algorithms.23,24
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Table. Weighted Characteristics of Eligible ARIC-NCS Participants at Visits 1 and 5 (n=1851)
Visit 1 (1987–1989)

Visit 5 (2011–2013)
P Value†

Mean (25th, 75th Percentile) or %*

Time to MRI, y

23.6 (23.0, 24.2)

0 (0, 0)



Age, y

51.7 (46.8, 55.1)

75.3 (70.4, 78.7)

<0.0001

Cognitively normal



74.1%



APOE*E4 allele

27.4%



Male

38.5%




Race-center
White-Minnesota

29.9%

White-Maryland

27.6%

White-North Carolina

21.2%

Black-North Carolina

1.7%

Black-Mississippi

19.6%


Education
Downloaded from http://jaha.ahajournals.org/ by guest on May 24, 2017

<12 y

11.8%

12–16 y

40.3%

>16 y

47.9%
<0.0001

Smoking status
Current

16.6%

5.2%

Former

33.2%

51.6%

Never

50.2%

43.1%

Body mass index, kg/m2

26.8 (23.3, 29.3)

28.4 (24.7, 31.2)

<0.0001

Systolic blood pressure, mm Hg

114.8 (103.7, 122.9)

129.8 (117.1, 140.1)

<0.0001

Diastolic blood pressure, mm Hg

72.2 (64.7, 78.0)

66.0 (58.6, 72.3)

<0.0001

Fasting glucose, mg/dL

99.4 (90.9, 102.8)

112.0 (96.9, 117.2)

<0.0001

Total cholesterol, mg/dL

209.6 (182.0, 231.2)

185.9 (155.2, 212.4)

<0.0001

HDL-C, mg/dL

54.2 (42.0, 63.1)

53.4 (43.0, 61.6)

0.007

LDL-C, mg/dL

132.2 (107.5, 154.5)

107.4 (81.3, 128.3)

<0.0001

Triglycerides, mg/dL

117.3 (71.3, 139.8)

125.7 (85.2, 147.9)

<0.0001

Antihypertensive medication use

20.2%

72.6%

<0.0001

Medication use for diabetes mellitus

1.7%

18.5%

<0.0001

Lipid-lowering medication use

1.6%

51.9%

<0.0001

Hypercholesterolemia

57.3%

34.9%

<0.0001

Frontal



0.28 (0.27, 0.30)



Temporal



0.28 (0.27, 0.30)



Parietal



0.30 (0.29, 0.31)



Occipital



0.22 (0.20, 0.24)



Anterior corpus callosum



0.43 (0.39, 0.47)



Posterior corpus callosum



0.58 (0.54, 0.62)



Overall



0.28 (0.27, 0.30)



Fractional anisotropy, by region

Continued

DOI: 10.1161/JAHA.117.005608
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Table. Continued
Visit 1 (1987–1989)

Visit 5 (2011–2013)
P Value†

Mean (25th, 75th Percentile) or %*

Mean diffusivity, by region, 10

4

mm2/s

Frontal



8.5 (8.2, 8.9)



Temporal



8.8 (8.4, 9.2)



Parietal



8.8 (8.3, 9.1)



Occipital



8.7 (8.2, 9.1)



Anterior corpus callosum



11.5 (10.7, 12.2)



Posterior corpus callosum



11.2 (10.4, 11.8)



Overall



8.7 (8.3, 9.1)



ARIC-NCS indicates Atherosclerosis Risk in Communities Neurocognitive Study; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MRI, magnetic
resonance imaging.
*Summary measures among those with data for a given variable.
†
Comparing visits 1 and 5 using a weighted paired t test or McNemar test, as appropriate.

Downloaded from http://jaha.ahajournals.org/ by guest on May 24, 2017

Although there was little support for an adverse association
between elevated lipids at visit 1 and overall WM FA, elevated
total cholesterol, LDL-C, and HDL-C at visit 5 appeared to be

associated with better overall WM FA (Figure 1). However,
these protective associations were limited to those who
remained cognitively normal at visit 5 (interaction P<0.05,
with the exception of P=0.08 for visit 5 HDL-C) and were
attenuated in sensitivity analyses omitting sampling weights
or weighting for attrition, which upweight persons with
cognitive impairment (Figures S6, S10, and S14). Findings
were materially unchanged after adjustment for WMH
(Figure 1), and there was little support for effect modiﬁcation
by WMH volumes (Figures S29 through S32). Analyses
considering effect modiﬁcation suggested an association
between higher visit 5 triglycerides and worse overall FA in
women but not men (interaction P=0.004).
Visit 1 and 5 plasma lipids were not associated with overall
WM MD, with the exception of an adverse association with

Figure 1. Comparison of primary and WMH-adjusted

Figure 2. Comparison of primary and WMH-adjusted

analyses of the association of mid- or late-life cardiovascular risk factors with overall WM FA. CI indicates
conﬁdence interval; DBP, diastolic blood pressure; FA,
fractional anisotropy; HDL-c, high-density lipoprotein
cholesterol; LDL-c, low-density lipoprotein cholesterol;
SBP, systolic blood pressure; WM, white matter; WMH,
white matter hyperintensity.

analyses of the association of mid- or late-life cardiovascular risk factors with overall WM MD. CI indicates
conﬁdence interval; DBP, diastolic blood pressure; HDL-c,
high-density lipoprotein cholesterol; LDL-c, low-density
lipoprotein cholesterol; MD, mean diffusivity; SBP, systolic
blood pressure; WM, white matter; WMH, white matter
hyperintensity.

Findings were generally consistent across ROIs, sensitivity
analyses, and categorical and linear versions of the exposures
(Figures S1 through S28; Tables S3 through S5). We reported
the linear association between our vascular risk factors and
overall WM MD or FA in the next sections and discussed other
analyses only when they differed substantially from these
analyses. Likewise, we discussed effect measure modiﬁcation
by age, sex, or race only when there was evidence supporting
its presence.

Plasma Lipids

DOI: 10.1161/JAHA.117.005608
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Figure 3. The adjusted association between cardiovascular risk factors at visit 1
or 5 and measures of overall white matter fractional anisotropy by decile of
intracranial-volume standardized WMH volumes. CI indicates conﬁdence interval;
DBP, diastolic blood pressure; SBP, systolic blood pressure; WMH, white matter
hyperintensity.

elevated triglycerides at visit 5 (Figure 2); however, this result
was not robust to sensitivity analyses omitting sampling
weights or imputing missing data (Figure S4). Adjustment for
WMH did not alter these ﬁndings (Figure 2). Some evidence
suggested an association between elevated LDL-C and worse
overall WM FA and MD only in those in the highest decile of
standardized WMH volumes (Figure S30). Analyses considering effect modiﬁcation also suggested a protective association between visit 1 HDL-C and overall WM MD in black but
not white participants (interaction P=0.01).

Serum Glucose
Elevated serum glucose at visit 1 was strongly associated with
worse overall WM MD (Figure 2). Although elevated glucose
at visit 1 was marginally associated with worse overall WM FA
(Figure 1), analyses considering categories of glucose did not
support an association (Table S4). Visit 5 glucose was not
associated with overall WM FA or MD, except in sensitivity
DOI: 10.1161/JAHA.117.005608

analyses implementing inverse probability of attrition weighting, where higher visit 5 glucose was associated with worse
overall WM MD. Results were similar after additional adjustment for WMH (Figures 1 and 2), and the adverse association
between elevated visit 1 glucose and worse MD or FA was
stronger in those with the least WMH (Figures 3 and 4).

Blood Pressure
Elevated SBP and DBP at either visit were strongly associated
with worse overall WM FA and MD. Additional adjustment for
WMH slightly attenuated, but did not eliminate, these
associations (Figures 1 and 2). There was little support for
effect modiﬁcation by WMH volumes (Figures 3 and 4). Of
note, in ROI-speciﬁc analyses, associations with MD or FA in
the anterior or posterior corpus callosum were often weaker
or null, and the association between visit 1 DBP and MD was
attenuated slightly in inverse probability of attrition weighting
sensitivity analyses (Figures S21 through S28).
Journal of the American Heart Association
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Figure 4. The adjusted association between cardiovascular risk factors at visit 1
or 5 and measures of overall white matter mean diffusivity by decile of
intracranial-volume standardized WMH volumes. CI indicates conﬁdence interval;
DBP, diastolic blood pressure; SBP, systolic blood pressure; WMH, white matter
hyperintensity.

Discussion
To our knowledge, this study of the relation of vascular risk
factors and WM microstructural integrity is the largest and
most comprehensive to date. Consistent with our own ﬁndings
that elevated blood pressure at both midlife and late life was
associated with worse WM microstructural integrity, several
small cross-sectional studies also previously reported an
association between elevated blood pressure and worse WM
microstructural integrity.7,34–42 Our ﬁnding of an association
between midlife glucose and late-life WM microstructural
integrity is also consistent with 1 prior report of stronger
associations between diabetes mellitus and WM microstructural integrity with increasing duration of diabetes mellitus.43
Although we did not observe a cross-sectional association
between glucose and WM microstructural integrity, prior crosssectional studies generally reported worse microstructural
integrity in participants with diabetes mellitus compared with
controls.43–48 Given that these studies were modest in size
(n<250), focused on diabetes mellitus rather than glucose, and
DOI: 10.1161/JAHA.117.005608

often reported effects only in localized brain regions, further
work will be needed to reconcile these ﬁndings with our own.
Finally, although we found little support for an adverse
association between elevated lipids and late-life WM
microstructural integrity, prior reports are mixed, with studies
reporting both null and adverse associations between lipids and
WM microstructural integrity.47,49–51 As with the literature on
diabetes mellitus and WM microstructural integrity, however,
these studies frequently report localized effects, which may not
be reﬂected in our analyses, given our focus on large ROIs, and
are limited by their size (n<250). Our ﬁnding that associations
between vascular risk factors and WM microstructural integrity
were largely independent of WMH volumes is also consistent
with some prior reports,43,45,47 reinforcing the notion that WM
microstructural integrity damage likely precedes WMH.
Our ﬁndings underscore the importance of moving to
longitudinal designs that can answer questions about when
exposures are relevant. Strengths of this study include the
large number participants, the use of data on midlife and
Journal of the American Heart Association

7

Vascular Risk Factors and White Matter Integrity

Power et al

scientiﬁc advisory board for Eli Lilly & Company and receives
research support from NIH and the Alexander Family
Alzheimer’s Disease Research Professorship of the Mayo
Foundation. Dr Gottesman is an Associate Editor for Neurology and receives research support from NIH. Dr Knopman
serves on a Data Safety Monitoring Board (DSMB) for
Lundbeck Pharmaceuticals and the DIAN study; is an
investigator in clinical trials sponsored by Biogen, TauRX
Pharmaceuticals, Lilly Pharmaceuticals and the Alzheimer’s
Disease Cooperative Study; and receives research support
from NIH. Dr Kantarci serves on the DSMB for Takeda
Pharmaceuticals Inc. and receives research support from NIH.

References
1. Anstey KJ, Lipnicki DM, Low LF. Cholesterol as a risk factor for dementia and
cognitive decline: a systematic review of prospective studies with metaanalysis. Am J Geriatr Psychiatry. 2008;16:343–354.
2. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to
cognitive function and dementia. Lancet Neurol. 2005;4:487–499.
3. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of
dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:
64–74.
4. Alexander AL, Lee JE, Lazar M, Field AS. Diffusion tensor imaging of the brain.
Neurotherapeutics. 2007;4:316–329.
5. Madden DJ, Bennett IJ, Song AW. Cerebral white matter integrity and cognitive
aging: contributions from diffusion tensor imaging. Neuropsychol Rev.
2009;19:415–435.
6. Vernooij MW, Ikram MA, Vrooman HA, Wielopolski PA, Krestin GP, Hofman A,
Niessen WJ, Van der Lugt A, Breteler MM. White matter microstructural
integrity and cognitive function in a general elderly population. Arch Gen
Psychiatry. 2009;66:545–553.

Acknowledgments

7. Maillard P, Seshadri S, Beiser A, Himali JJ, Au R, Fletcher E, Carmichael O, Wolf
PA, DeCarli C. Effects of systolic blood pressure on white-matter integrity in
young adults in the Framingham Heart Study: a cross-sectional study. Lancet
Neurol. 2012;11:1039–1047.

The authors thank the staff and participants of the ARIC study for
their important contributions.

8. Salat DH, Tuch DS, Hevelone ND, Fischl B, Corkin S, Rosas HD, Dale AM. Agerelated changes in prefrontal white matter measured by diffusion tensor
imaging. Ann N Y Acad Sci. 2005;1064:37–49.

Sources of Funding
Dr Power was supported by the NIA (T32 AG027668). The ARIC
is carried out as a collaborative study supported by NHLBI
contracts (HHSN268201100005C, HHSN268201100006C,
HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). Neurocognitive data are
collected by NIH U01 HL096812, HL096814, HL096899,
HL096902, HL096917 with previous brain MRI examinations
funded by NIH R01-HL70825. The sponsors had no role in the
design and conduct of the study; collection management,
analysis and interpretation of the data; or preparation review,
or approval of the manuscript.

Disclosures
Mr Tingle and Drs Coresh, Griswold, Huang, Mosley, Power,
Reid, and Sharrett have no disclosures. Dr Jack Jr serves on a

DOI: 10.1161/JAHA.117.005608

9. Ly M, Canu E, Xu G, Oh J, McLaren DG, Dowling NM, Alexander AL, Sager MA,
Johnson SC, Bendlin BB. Midlife measurements of white matter microstructure
predict subsequent regional white matter atrophy in healthy adults. Hum Brain
Mapp. 2014;35:2044–2054.
10. Maillard P, Fletcher E, Lockhart SN, Roach AE, Reed B, Mungas D, DeCarli C,
Carmichael OT. White matter hyperintensities and their penumbra lie along a
continuum of injury in the aging brain. Stroke. 2014;45:1721–1726.
11. Maillard P, Carmichael O, Harvey D, Fletcher E, Reed B, Mungas D, DeCarli C.
FLAIR and diffusion MRI signals are independent predictors of white matter
hyperintensities. AJNR Am J Neuroradiol. 2013;34:54–61.
12. Maillard P, Fletcher E, Harvey D, Carmichael O, Reed B, Mungas D, DeCarli C.
White matter hyperintensity penumbra. Stroke. 2011;42:1917–1922.
13. Swan GE, DeCarli C, Miller BL, Reed T, Wolf PA, Jack LM, Carmelli D.
Association of midlife blood pressure to late-life cognitive decline and brain
morphology. Neurology. 1998;51:986–993.
14. van Dijk EJ, Breteler MM, Schmidt R, Berger K, Nilsson LG, Oudkerk M, Pajak
A, Sans S, de Ridder M, Dufouil C, Fuhrer R, Giampaoli S, Launer LJ, Hofman A.
The association between blood pressure, hypertension, and cerebral white
matter lesions: cardiovascular determinants of dementia study. Hypertension.
2004;44:625–630.
15. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM.
Progression of cerebral small vessel disease in relation to risk factors
and cognitive consequences: Rotterdam Scan study. Stroke. 2008;39:2712–
2719.
16. Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, Wolf PA, DeCarli C.
Midlife vascular risk factor exposure accelerates structural brain aging and
cognitive decline. Neurology. 2011;77:461–468.
17. Gottesman RF, Coresh J, Catellier DJ, Sharrett AR, Rose KM, Coker LH, Shibata
DK, Knopman DS, Jack CR, Mosley TH. Blood pressure and white-matter

Journal of the American Heart Association

8

ORIGINAL RESEARCH

Downloaded from http://jaha.ahajournals.org/ by guest on May 24, 2017

late-life vascular risk factors, and a community-based sample.
Compared with a voxelwise comparison-based approach, our
ROI-based approach has a reduced chance of type I error and
greater reproducibility but is unlikely to identify localized
effects. Because we based our study on an MRI subsample,
selection bias is a potential concern; however, we do not
believe that this is a signiﬁcant source of bias in this study
because our sensitivity analyses designed to address and
quantify this source of bias were generally consistent with our
primary analyses. Other limitations include the lack of serial
MRIs, precluding assessment change in FA or MD, and the
potential for chance ﬁndings or residual bias.
Changes to WM microstructural integrity provide an early
indication of who is at risk of cerebral WM injury, including both
WMH and WM loss, and subsequent cognitive impairment. Our
study conﬁrmed that the risk factors for WM microstructural
integrity and WMH are similar, and that, perhaps most
important, these associations were independent of WMH
presence and severity. Although our study provides early
evidence to suggest that DTI-based measures may be appropriate outcomes risk-stratiﬁcation tools or surrogate outcomes
in clinical trials intervening with regard to vascular risk factors,
additional work is required to conﬁrm these ﬁndings and to
better establish the utility of these markers. Regardless, our
study suggests that avoiding elevated glucose in midlife and
hypertension at any point may prevent later damage to WM
microstructural integrity and its downstream effects.

Vascular Risk Factors and White Matter Integrity

Power et al

18. Knopman DS, Penman AD, Catellier DJ, Coker LH, Shibata DK, Sharrett AR,
Mosley TH Jr. Vascular risk factors and longitudinal changes on brain MRI: the
ARIC study. Neurology. 2011;76:1879–1885.

35. Kennedy KM, Raz N. Pattern of normal age-related regional differences in
white matter microstructure is modiﬁed by vascular risk. Brain Res.
2009;1297:41–56.

19. Knopman DS, Mosley TH, Catellier DJ, Sharrett AR. Cardiovascular risk factors
and cerebral atrophy in a middle-aged cohort. Neurology. 2005;65:876–881.

36. Burgmans S, van Boxtel MP, Gronenschild EH, Vuurman EF, Hofman P, Uylings
HB, Jolles J, Raz N. Multiple indicators of age-related differences in cerebral
white matter and the modifying effects of hypertension. Neuroimage.
2010;49:2083–2093.

20. Launer LJ, Lewis CE, Schreiner PJ, Sidney S, Battapady H, Jacobs DR, Lim KO,
D’Esposito M, Zhang Q, Reis J, Davatzikos C, Bryan RN. Vascular factors and
multiple measures of early brain health: CARDIA brain MRI study. PLoS One.
2015;10:e0122138.

37. Salat DH, Williams VJ, Leritz EC, Schnyer DM, Rudolph JL, Lipsitz LA,
McGlinchey RE, Milberg WP. Inter-individual variation in blood pressure is
associated with regional white matter integrity in generally healthy older
adults. Neuroimage. 2012;59:181–192.

21. Knopman DS, Griswold ME, Lirette ST, Gottesman RF, Kantarci K, Sharrett AR,
Jack CR Jr, Graff-Radford J, Schneider AL, Windham BG, Coker LH, Albert MS,
Mosley TH Jr. Vascular imaging abnormalities and cognition: mediation by
cortical volume in nondemented individuals: Atherosclerosis Risk in Communities-neurocognitive study. Stroke. 2015;46:433–440.

38. Jacobs HI, Leritz EC, Williams VJ, Van Boxtel MP, van der Elst W, Jolles J, Verhey
FR, McGlinchey RE, Milberg WP, Salat DH. Association between white matter
microstructure, executive functions, and processing speed in older adults: the
impact of vascular health. Hum Brain Mapp. 2013;34:77–95.

22. Vemuri P, Gunter JL, Senjem ML, Whitwell JL, Kantarci K, Knopman DS, Boeve
BF, Petersen RC, Jack CR Jr. Alzheimer’s disease diagnosis in individual
subjects using structural MR images: validation studies. Neuroimage.
2008;39:1186–1197.
23. Raz L, Jayachandran M, Tosakulwong N, Lesnick TG, Wille SM, Murphy MC,
Senjem ML, Gunter JL, Vemuri P, Jack CR Jr, Miller VM, Kantarci K.
Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women. Neurology. 2013;80:911–918.

Downloaded from http://jaha.ahajournals.org/ by guest on May 24, 2017

24. Jack CR Jr, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Mielke MM, Lowe
VJ, Senjem ML, Gunter JL, Preboske GM, Pankratz VS, Vemuri P, Petersen RC.
Age-speciﬁc population frequencies of cerebral beta-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–
89 years: a cross-sectional study. Lancet Neurol. 2014;13:997–1005.
25. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic
determination of serum total cholesterol with improved lipolytic efﬁciency. Clin
Chem. 1983;29:1075–1080.
26. Nagele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW,
Gruber W. Reagent for the enzymatic determination of serum total triglycerides
with improved lipolytic efﬁciency. J Clin Chem Clin Biochem. 1984;22:165–
174.
27. Patsch W, Brown SA, Morrisett JD, Gotto AM Jr, Patsch JR. A dual-precipitation
method evaluated for measurement of cholesterol in high-density lipoprotein
subfractions HDL2 and HDL3 in human plasma. Clin Chem. 1989;35:265–270.
28. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation
procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem.
1982;28:1379–1388.
29. McNamara JR, Cohn JS, Wilson PW, Schaefer EJ. Calculated values for lowdensity lipoprotein cholesterol in the assessment of lipid abnormalities and
coronary disease risk. Clin Chem. 1990;36:36–42.
30. Stein MW. Clinical Methods of Enzymatic Analysis. New York: Academic Press;
1965.

39. Leritz EC, Salat DH, Milberg WP, Williams VJ, Chapman CE, Grande LJ, Rudolph
JL, Schnyer DM, Barber CE, Lipsitz LA, McGlinchey RE. Variation in blood
pressure is associated with white matter microstructure but not cognition in
African Americans. Neuropsychology. 2010;24:199–208.
40. Hannesdottir K, Nitkunan A, Charlton RA, Barrick TR, MacGregor GA, Markus
HS. Cognitive impairment and white matter damage in hypertension: a pilot
study. Acta Neurol Scand. 2009;119:261–268.
41. Nitkunan A, Charlton RA, McIntyre DJ, Barrick TR, Howe FA, Markus HS.
Diffusion tensor imaging and MR spectroscopy in hypertension and presumed
cerebral small vessel disease. Magn Reson Med. 2008;59:528–534.
42. Maclullich AM, Ferguson KJ, Reid LM, Deary IJ, Starr JM, Seckl JR, Bastin ME,
Wardlaw JM. Higher systolic blood pressure is associated with increased water
diffusivity in normal-appearing white matter. Stroke. 2009;40:3869–3871.
43. Hsu J-L, Chen Y-L, Leu J-G, Jaw F-S, Lee C-H, Tsai Y-F, Hsu C-Y, Bai C-H,
Leemans A. Microstructural white matter abnormalities in type 2 diabetes
mellitus: a diffusion tensor imaging study. Neuroimage. 2012;59:1098–1105.
44. Yau PL, Javier DC, Ryan CM, Tsui WH, Ardekani BA, Ten S, Convit A.
Preliminary evidence for brain complications in obese adolescents with type 2
diabetes mellitus. Diabetologia. 2010;53:2298–2306.
45. Yau PL, Kluger A, Borod JC, Convit A. Neural substrates of verbal memory
impairments in adults with type 2 diabetes mellitus. J Clin Exp Neuropsychol.
2014;36:74–87.
46. Hoogenboom WS, Marder TJ, Flores VL, Huisman S, Eaton HP, Schneiderman
JS, Bolo NR, Simonson DC, Jacobson AM, Kubicki M, Shenton ME, Musen G.
Cerebral white matter integrity and resting-state functional connectivity in
middle-aged patients with type 2 diabetes. Diabetes. 2014;63:728–738.
47. Wang R, Fratiglioni L, Laukka EJ, Lovden M, Kalpouzos G, Keller L, Graff C,
Salami A, Backman L, Qiu C. Effects of vascular risk factors and APOE epsilon4
on white matter integrity and cognitive decline. Neurology. 2015;84:1128–
1135.

31. White IR, Royston P, Wood AM. Multiple imputation using chained equations:
issues and guidance for practice. Stat Med. 2011;30:377–399.

48. Falvey CM, Rosano C, Simonsick EM, Harris T, Strotmeyer ES, Satterﬁeld S,
Yaffe K; Study ftHA. Macro- and microstructural magnetic resonance imaging
indices associated with diabetes among community-dwelling older adults.
Diabetes Care. 2013;36:677–682.

32. Power MC, Schneider AL, Wruck L, Griswold M, Coker LH, Alonso A, Jack CR Jr,
Knopman D, Mosley TH, Gottesman RF. Life-course blood pressure in relation
to brain volumes. Alzheimers Dement. 2016;12:890–899.

49. Lou B, Chen M, Luo X, Dai Y. Reduced right frontal fractional anisotropy
correlated with early elevated plasma LDL levels in obese young adults. PLoS
One. 2014;9:e108180.

33. Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate
the causal effect of zidovudine on the survival of HIV-positive men.
Epidemiology. 2000;11:561–570.

50. Cohen JI, Cazettes F, Convit A. Abnormal cholesterol is associated with
prefrontal white matter abnormalities among obese adults: a diffusion tensor
imaging study. Neuroradiol J. 2011;24:854–861.

34. Gons RA, van Oudheusden LJ, de Laat KF, van Norden AG, van Uden IW, Norris
DG, Zwiers MP, van Dijk E, de Leeuw FE. Hypertension is related to the
microstructure of the corpus callosum: the RUN DMC study. J Alzheimers Dis.
2012;32:623–631.

51. Williams VJ, Leritz EC, Shepel J, McGlinchey RE, Milberg WP, Rudolph JL, Lipsitz
LA, Salat DH. Interindividual variation in serum cholesterol is associated with
regional white matter tissue integrity in older adults. Hum Brain Mapp.
2013;34:1826–1841.

DOI: 10.1161/JAHA.117.005608

Journal of the American Heart Association

9

ORIGINAL RESEARCH

disease progression in a biethnic cohort: Atherosclerosis Risk in Communities
(ARIC) study. Stroke. 2010;41:3–8.

SUPPLEMENTARY MATERIAL
Midlife and late life vascular risk factors and white matter integrity on diffusion tensor imaging:
the ARIC-NCS study
Melinda C. Power, ScD; Jonathan V. Tingle, BA; Robert I. Reid, Ph.D. Juebin Huang, MD; A.
Richey Sharrett, MD; Josef Coresh, MD; Michael Griswold, PhD; Kejal Kantarci, MD, MS;
Clifford R. Jack, Jr, MD; David Knopman, MD; Rebecca F. Gottesman, MD; Thomas H.
Mosley, PhD
Published in JAHA.
Table of Contents
Downloaded from http://jaha.ahajournals.org/ by guest on May 24, 2017

Page 5 ……. Supplementary Methods: MRI scan parameters and processing
Page 6 ……. Table I. Unweighted characteristics of eligible ARIC-NCS sample participants at
Visit 1 and Visit 5 (n=1851)
Page 7 ……. Table II. Number of eligible ARIC-NCS sample participants missing covariate or
exposure data at Visit 1 or Visit 5
Page 8 …….. Table III. Adjusted associations between a 10-unit increase in the level of each
vascular risk factor approximately 24 years prior to or concurrent with MRI and
standardized measures of overall WM microstructural integrity on diffusion MRI
in ARIC-NCS
Page 9 ……... Table IV. Adjusted difference in total FA by category of vascular risk factors
measured at Visit 1 or Visit 5
Page 10 ……. Table V. Adjusted difference in total MD by category of vascular risk factors
measured at Visit 1 or Visit 5
Page 11……... Figure I. Comparison of the primary analyses of the association of triglycerides
with regional and total FA with sensitivity analyses considering different
adjustment sets
Page 11..…... Figure II. Comparison of the primary analyses of the association of triglycerides
with regional and total FA with sensitivity analyses considering the influence of
weighting, attrition, and missing covariate or exposure data
Page 12……... Figure III. Comparison of the primary analyses of the association of triglycerides
with regional and total MD with sensitivity analyses considering different
adjustment sets

1

Page 12……...Figure IV. Comparison of the primary analyses of the association of triglycerides
with regional and total MD with sensitivity analyses considering the influence of
weighting, attrition, and missing covariate or exposure data
Page 13……...Figure V. Comparison of the primary analyses of the association of LDL-c with
regional and total FA with sensitivity analyses considering different adjustment
sets
Page 13……...Figure VI. Comparison of the primary analyses of the association of LDL-c with
regional and total FA with sensitivity analyses considering the influence of
weighting, attrition, and missing covariate or exposure data
Page 14……...Figure VII. Comparison of the primary analyses of the association of LDL-c with
regional and total MD with sensitivity analyses considering different adjustment
sets
Downloaded from http://jaha.ahajournals.org/ by guest on May 24, 2017

Page 14……...Figure VIII. Comparison of the primary analyses of the association of LDL-c with
regional and total MD with sensitivity analyses considering the influence of
weighting, attrition, and missing covariate or exposure data
Page 15……...Figure IX. Comparison of the primary analyses of the association of HDL-c with
regional and total FA with sensitivity analyses considering different adjustment
sets
Page 15……...Figure X. Comparison of the primary analyses of the association of HDL-c with
regional and total FA with sensitivity analyses considering the influence of
weighting, attrition, and missing covariate or exposure data
Page 16……...Figure X1. Comparison of the primary analyses of the association of HDL-c with
regional and total MD with sensitivity analyses considering different adjustment
sets
Page 16……...Figure XII. Comparison of the primary analyses of the association of HDL-c with
regional and total MD with sensitivity analyses considering the influence of
weighting, attrition, and missing covariate or exposure data
Page 17……...Figure XIII. Comparison of the primary analyses of the association of total
cholesterol with regional and total FA with sensitivity analyses considering
different adjustment sets
Page 17……...Figure XIV. Comparison of the primary analyses of the association of total
cholesterol with regional and total FA with sensitivity analyses considering the
influence of weighting, attrition, and missing covariate or exposure data
Page 18……...Figure XV. Comparison of the primary analyses of the association of total
cholesterol with regional and total MD with sensitivity analyses considering
different adjustment sets
Page 18……...Figure XVI. Comparison of the primary analyses of the association of total
cholesterol with regional and total MD with sensitivity analyses considering the
influence of weighting, attrition, and missing covariate or exposure data
2

Page 19……...Figure XVII. Comparison of the primary analyses of the association of glucose
with regional and total FA with sensitivity analyses considering different
adjustment sets
Page 19……...Figure XVIII. Comparison of the primary analyses of the association of glucose
with regional and total FA with sensitivity analyses considering the influence of
weighting, attrition, and missing covariate or exposure data
Page 20……...Figure XIX. Comparison of the primary analyses of the association of glucose
with regional and total MD with sensitivity analyses considering different
adjustment sets
Page 20……...Figure XX. Comparison of the primary analyses of the association of glucose
with regional and total MD with sensitivity analyses considering the influence of
weighting, attrition, and missing covariate or exposure data
Downloaded from http://jaha.ahajournals.org/ by guest on May 24, 2017

Page 21……...Figure XXI. Comparison of the primary analyses of the association of diastolic
blood pressure with regional and total FA with sensitivity analyses considering
different adjustment sets
Page 21……...Figure XXII. Comparison of the primary analyses of the association of diastolic
blood pressure with regional and total FA with sensitivity analyses considering
the influence of weighting, attrition, and missing covariate or exposure data
Page 22……...Figure XXIII. Comparison of the primary analyses of the association of diastolic
blood pressure with regional and total MD with sensitivity analyses considering
different adjustment sets
Page 22……...Figure XXIV. Comparison of the primary analyses of the association of diastolic
blood pressure with regional and total MD with sensitivity analyses considering
the influence of weighting, attrition, and missing covariate or exposure data
Page 23……...Figure XXV. Comparison of the primary analyses of the association of systolic
blood pressure with regional and total FA with sensitivity analyses considering
different adjustment sets
Page 23……...Figure XXVI. Comparison of the primary analyses of the association of systolic
blood pressure with regional and total FA with sensitivity analyses considering
the influence of weighting, attrition, and missing covariate or exposure data
Page 24……...Figure XXVII. Comparison of the primary analyses of the association of systolic
blood pressure with regional and total MD with sensitivity analyses considering
different adjustment sets
Page 24……...Figure XXVIII. Comparison of the primary analyses of the association of systolic
blood pressure with regional and total MD with sensitivity analyses considering
the influence of weighting, attrition, and missing covariate or exposure data
Page 25……...Figure XXIX. The adjusted association between triglycerides at Visit 1 or Visit 5
and measures of white matter integrity by decile of intracranial-volume
standardized WMH volumes
3

Page 26……...Figure XXX. The adjusted association between LDL-c at Visit 1 or Visit 5 and
measures of white matter integrity by decile of intracranial-volume standardized
WMH volumes
Page 27……...Figure XXXI. The adjusted association between HDL-c at Visit 1 or Visit 5 and
measures of white matter integrity by decile of intracranial-volume standardized
WMH volumes
Page 28……...Figure XXXII. The adjusted association between total cholesterol at Visit 1 or
Visit 5 and measures of white matter integrity by decile of intracranial-volume
standardized WMH volumes

Downloaded from http://jaha.ahajournals.org/ by guest on May 24, 2017

4

Supplementary Methods: MRI Scan Parameters and Processing
At Visit 5/ARIC-NCS, each study site followed similar protocols for 3T brain MRI. The North
Carolina and Mississippi sites used Skyras, the Maryland site used a Verio, and the Minnesota
site used a Trio Tim, all manufactured by Siemens. The T1-weighted volumetric scans used a
sagittal magnetization prepared gradient echo (MPRAGE) sequence with 1.2mm x 1.0mm x 1.0
mm resolution in the x (~LR), y (~AP), and z (~SI) directions. The resulting images were
unwarped in post-processing to account for gradient nonlinearity, using coefficients provided by
the manufacturer. The FLAIR scans, primarily used to detect WMH, had a resolution of 0.9mm x
0.9mm x 5.0mm in x, y, and z. The DTI scans used the Siemens product echo planar imaging
(EPI) pulse sequence and diffusion gradient set, namely a single b = 0 volume followed by 64 b
= 1000 s/mm2 diffusion directions uniformly spread over the whole sphere. An isotropic 2.7mm
voxel resolution was used, and DTI echo time (TE) was 87 ms for all scanners.
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In post-processing the DTI images were simultaneously corrected for volume-to-volume head
motion and eddy current distortion by affinely registering each of the diffusion weighted
volumes to the b=0 volume. EPI sequences are also affected by distortions at changes in
magnetic susceptibility, such as air/tissue/bone interfaces around the sinuses and ear canals.
These distortions were corrected by nonlinearly registering the DTI images to the T1-weighted
anatomical reference scan using the BrainSuite (Bhushan, Haldar, Choi, Joshi, Shattuck, &
Leahy, 2015) program, which also produced FA and MD images in each subject’s T1-weighted
space after fitting diffusion tensors to the data with a weighted least-squares scheme. Each
FLAIR-to-T1 and DTI-to-T1 registration was manually examined to catch and correct or remove
gross registration failures.
Image analysis for all four sites was completed by the ARIC MRI Reading Center (Mayo Clinic,
MN; PI: Dr. Cliff Jack, Jr.) using the same protocols, ensuring consistency of measurement
across sites. Finally, we also adjusted for site in our regression models, as part of the race-center
variable.

Reference:
Bhushan, C., Haldar, J., Choi, S., Joshi, A., Shattuck, D., & Leahy, R. (2015). Co-registration
and distortion correction of diffusion and anatomical images based on inverse contrast
normalization. Neuroimage , 115, 269-80.
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Table I. Unweighted characteristics eligible ARIC-NCS sample participants at Visit 1 and Visit 5 (n=1851)
Visit 1 (1987-89)
Visit 5 (2011-2013)
Mean (25th, 75th percentile) or %*
Time to MRI (years)
0 (0, 0)
23.7 (23.0, 24.2)
52.7 (47.7, 56.1)
76.4 (71.3, 79.9)
Age (years)
N/A
59.4%
Cognitively Normal
29.2%
APOE e4 allele (CT or CC)
39.9%
Male
Race-center
22.5%
MN whites
26.5%
MD whites
23.4%
NC whites
1.8%
NC blacks
25.8%
MS blacks
Education
14.1%
<12 years
40.9%
12-16 years
44.9%
>16 years
Smoking status
16.6%
5.4%
Current
32.4%
50.9%
Former
51.0%
43.7%
Never
27.0 (23.6, 29.5)
28.4 (24.7, 31.1)
BMI (kg2/m)
116.2 (104.4, 124.5)
131.0 (118.0, 141.5)
Systolic BP (mm Hg)
72.8 (65.1, 79.5)
66.2 (58.7, 72.6)
Diastolic BP (mm Hg)
100.0 (91.3, 103.2)
112.7 (96.9, 118.5)
Fasting glucose (mg/dL)
212.7 (184.8, 234.3)
183.7 (153.3, 210.2)
Total cholesterol (mg/dL)
54.7 (41.4, 63.7)
53.0 (42.9, 61.0)
HDL cholesterol (mg/dL)
134.7 (109.2, 156.9)
105.8 (80.2, 126.6)
LDL cholesterol (mg/dL)
118.5 (72.5, 139.3)
125.2 (83.9, 146.6)
Triglycerides (mg/dL)
22.2%
74.9%
Antihypertensive medication use
1.9%
21.2%
Medication use for diabetes
1.7%
54.0%
Lipid lowering medication use
61.2%
33.0%
Hypercholesterolemia
Fractional anisotropy, by region
-0.28 (0.27, 0.30)
Frontal
-0.28 (0.27, 0.30)
Temporal
-0.30 (0.28, 0.31)
Parietal
-0.22 (0.20, 0.23)
Occipital
-0.42 (0.38, 0.46)
Anterior corpus callosum
-0.57 (0.54, 0.62)
Posterior corpus callosum
-0.28 (0.27, 0.30)
Overall
Mean diffusivity, by region (10-4 mm2/s)
-8.6 (8.2, 8.9)
Frontal
-8.9 (8.5, 9.3)
Temporal
-8.8 (8.3, 9.2)
Parietal
-8.7 (8.3, 9.1)
Occipital
-11.6 (10.8, 12.4)
Anterior corpus callosum
-11.2 (10.4, 11.9)
Posterior corpus callosum
-8.8 (8.4, 9.1)
Overall
Abbreviations: ARIC-NCS, Atherosclerosis Risk in Communities Neurocognitive Study; MRI, magnetic
resonance imaging
*All summary measures among those with data for a given variable. Number missing each variable is provided
in Appendix Table 2.
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Table II. Number of eligible ARIC-NCS sample participants missing covariate or exposure data at Visit 1 or
Visit 5
Visit 1 (1987-89)
Visit 5 (2011-2013)
N missing
Time to MRI (years)
0
0
0
0
Age (years)
N/A
13
Cognitively Normal
55
APOE e4 allele (CT or CC)
0
Male
0
Race-center
2
Education
0
117
Smoking status
1
8
BMI (kg2/m)
2
6
Systolic BP (mm Hg)
2
6
Diastolic BP (mm Hg)
56
106
Fasting glucose (mg/dL)
25
13
Total cholesterol (mg/dL)
24
13
HDL cholesterol (mg/dL)
43
36
LDL cholesterol (mg/dL)
24
13
Triglycerides (mg/dL)
0
0
Antihypertensive medication use
332
5
Medication use for diabetes
20
5
Lipid lowering medication use
25
13
Hypercholesterolemia
Abbreviations: MRI, Magnetic resonance imaging
*All summary measures among those with data for a given variable. Number missing each variable is provided
in Appendix Table 2.
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Table III. Adjusted associations between a 10-unit increase in the level of each vascular risk factor approximately 24 years prior to or
concurrent with MRI and standardized measures of overall WM microstructural integrity on diffusion MRI in ARIC-NCS
Visit 5 (Concurrent with MRI)

Visit 1 (~24 years prior to MRI)
N

beta (95%CI)*

p-value

N

beta (95%CI)*

p-value

Triglycerides (mg/dL)

1425

0.0024 (-0.0046, 0.0094)

0.50

1574

-0.0026 (-0.0104, 0.0052)

0.51

LDL-c (mg/dL)

1410

0.0017 (-0.0117, 0.0151)

0.81

1564

0.0156 (0.0011, 0.0302)

0.04

HDL-c (mg/dL)

1425

0.0255 (-0.0081, 0.0591)

0.14

1574

0.0340 (-0.0019, 0.0698)

0.06

Total Cholesterol (mg/dL)

1425

0.0053 (-0.0071, 0.0177)

0.40

1574

0.0129 (0.0009, 0.0249)

0.04

Glucose (mg/dL)

1425

-0.0292 (-0.0604, 0.0020)

0.07

1574

-0.0003 (-0.0199, 0.0193)

0.97

DBP (mmHg)

1425

-0.1077 (-0.1634, -0.0519)

0.0002

1574

-0.1195 (-0.1648, -0.0743)

<0.0001

SBP (mmHg)

1425

-0.0481 (-0.0849, -0.0114)

0.01

1574

-0.0762 (-0.1019, -0.0506)

<0.0001

Triglycerides (mg/dL)

1425

-0.0013 (-0.0069, 0.0044)

0.66

1574

0.0065 (0.0002, 0.0127)

0.04

LDL-c (mg/dL)

1410

-0.0028 (-0.0136, 0.0080)

0.61

1564

-0.0061 (-0.0178, 0.0056)

0.31

HDL-c (mg/dL)

1425

0.0005 (-0.0267, 0.0277)

0.97

1574

-0.0111 (-0.0399, 0.0176)

0.45

Total Cholesterol (mg/dL)

1425

-0.0028 (-0.0128, 0.0072)

0.59

1574

-0.0020 (-0.0117, 0.0076)

0.68

Glucose (mg/dL)

1425

0.0473 (0.0221, 0.0726)

0.0002

1574

0.0034 (-0.0124, 0.0191)

0.67

DBP (mmHg)

1425

0.0621 (0.0170, 0.1073)

0.007

1574

0.0720 (0.0356, 0.1084)

0.0001

WM FA

WM MD

SBP (mmHg)
1425
0.0465 (0.0168, 0.0761)
0.002
1574
0.0606 (0.0401, 0.0811)
<0.0001
Abbreviations: ARIC-NCS, Atherosclerosis Risk in Communities Study Neurocognitive Study; DBP, diastolic blood pressure; FA, fractional
anisotrophy; HDL-c, high density lipoprotein cholesterol; LDL-c, low density lipoprotein cholesterol; MD, mean diffusivity; SBP, systolic
blood pressure; WM, white matter
*Fully adjusted model including age, gender, education, race/center, BMI, the square of BMI, smoking status, APOE E4, the other vascular
risk factors, antihypertensive medication use, antidiabetic medication use, and lipid-lowering medications.
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Table IV. Adjusted difference in total FA by category of vascular risk factors measured at Visit 1 or Visit 5
Visit 1 (~24 years prior to MRI)
beta (95%CI)

Visit 5 (Concurrent with MRI)

p-value

beta (95%CI)

p-value

Triglycerides
500+ mg/dL

0.3206 (-0.3586, 0.9998)

0.35

-0.2905 (-1.5258, 0.9449)

0.64

200-500 mg/dL

-0.0767 (-0.2471, 0.0937)

0.38

-0.07 (-0.219, 0.0791)

0.36

150-200 mg/dL

0.113 (-0.0355, 0.2615)

<150 mg/dL

0 (ref)

0.14

0 (ref)

0.09

190+ mg/dL

-0.0186 (-0.2393, 0.2021)

0.87

0.1672 (-0.1831, 0.5174)

0.35

160-190 mg/dL

0.0026 (-0.166, 0.1712)

0.98

0.1947 (-0.0048, 0.3943)

0.06

130-160 mg/dL

0.0437 (-0.0986, 0.1861)

0.55

0.0635 (-0.0777, 0.2046)

0.38

100-130 mg/dL

0.0337 (-0.1022, 0.1696)

0.63

0.0526 (-0.0549, 0.1601)

0.34

<100 mg/dL

0 (ref)

-0.1156 (-0.2472, 0.016)

LDL-c

Downloaded from http://jaha.ahajournals.org/ by guest on May 24, 2017

0 (ref)

HDL-c
60+ mg/dL

0.0931 (-0.0666, 0.2528)

0.25

0.0992 (-0.0514, 0.2498)

0.20

40-60 mg/dL

0.0133 (-0.1217, 0.1483)

0.85

0.0527 (-0.0749, 0.1803)

0.42

<40 mg/dL

0 (ref)

0 (ref)

Total Cholesterol
240+ mg/dL

0.0422 (-0.0877, 0.172)

0.52

0.0827 (-0.0694, 0.2348)

0.29

200-240 mg/dL

0.0517 (-0.0577, 0.161)

0.35

0.0613 (-0.049, 0.1716)

0.28

<200 mg/dL

0 (ref)

0 (ref)

Glucose
126+ mg/dL

-0.0359 (-0.3913, 0.3195)

0.84

0.0092 (-0.1383, 0.1567)

0.90

100-126 mg/dL

-0.036 (-0.1416, 0.0696)

0.50

0.0022 (-0.0975, 0.1019)

0.97

<100 mg/dL

0 (ref)

0 (ref)

DBP
80+ mm Hg

-0.3137 (-0.5235, -0.1039)

0.003

-0.3487 (-0.5238, -0.1737)

0.0001

60-80 mm Hg

-0.2161 (-0.3901, -0.0422)

0.01

-0.1415 (-0.2439, -0.0392)

0.01

<60 mm Hg

0 (ref)

0 (ref)

SBP
140+ mm Hg

-0.1686 (-0.3852, 0.048)

0.13

-0.3448 (-0.4639, -0.2257)

120-140 mm Hg

-0.1305 (-0.2449, -0.016)

0.03

-0.1863 (-0.2886, -0.084)

<120 mm Hg

0 (ref)

<0.0001
0.0004

0 (ref)

Abbreviations: ARIC-NCS, Atherosclerosis Risk in Communities Study Neurocognitive Study; DBP, diastolic
blood pressure; FA, fractional anisotrophy; HDL-c, high density lipoprotein cholesterol; LDL-c, low density
lipoprotein cholesterol; SBP, systolic blood pressure.
*Fully adjusted model including age, gender, education, race/center, BMI, the square of BMI, smoking status,
APOE E4, the other vascular risk factors, antihypertensive medication use, antidiabetic medication use, and
lipid-lowering medications.
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Table V. Adjusted difference in total MD by category of vascular risk factors measured at Visit 1 or Visit 5
Visit 1 (~24 years prior to MRI)
Visit 5 (Concurrent with MRI)
beta (95%CI)

p-value

beta (95%CI)

p-value

Triglycerides
500+ mg/dL

-0.1893 (-0.7397, 0.3611)

0.50

0.635 (-0.3551, 1.6252)

0.21

200-500 mg/dL

0.0462 (-0.0919, 0.1842)

0.51

0.0585 (-0.0609, 0.178)

0.34

150-200 mg/dL

-0.0388 (-0.1592, 0.0815)

<150 mg/dL

0 (ref)

0.53

0 (ref)

0.22

190+ mg/dL

0.0247 (-0.154, 0.2034)

0.79

-0.0277 (-0.3086, 0.2533)

0.85

160-190 mg/dL

-0.0192 (-0.1558, 0.1173)

0.78

-0.0452 (-0.2053, 0.1149)

0.58

130-160 mg/dL

-0.0388 (-0.1541, 0.0765)

0.51

-0.0035 (-0.1168, 0.1097)

0.95

100-130 mg/dL

-0.0452 (-0.1553, 0.0648)

0.42

0.0113 (-0.0749, 0.0975)

0.80

<100 mg/dL

0 (ref)

0.0663 (-0.0392, 0.1718)

LDL-c
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0 (ref)

HDL-c
60+ mg/dL

-0.0405 (-0.1698, 0.0888)

0.54

-0.0357 (-0.1564, 0.085)

0.56

40-60 mg/dL

-0.0472 (-0.1565, 0.0621)

0.40

-0.0487 (-0.151, 0.0537)

0.35

<40 mg/dL

0 (ref)

0 (ref)

Total Cholesterol
240+ mg/dL

0.0025 (-0.1027, 0.1076)

0.96

0.0383 (-0.0837, 0.1603)

0.54

200-240 mg/dL

0.0203 (-0.0683, 0.1088)

0.65

-0.018 (-0.1064, 0.0704)

0.69

<200 mg/dL

0 (ref)

0 (ref)

Glucose
126+ mg/dL

0.3066 (0.0184, 0.5949)

0.04

0.0184 (-0.0997, 0.1365)

0.76

100-126 mg/dL

0.0672 (-0.0184, 0.1529)

0.12

0.0898 (0.01, 0.1696)

0.03

<100 mg/dL

0 (ref)

0 (ref)

DBP
80+ mm Hg

0.1713 (0.0014, 0.3412)

0.05

0.2062 (0.0656, 0.3468)

0.004

60-80 mm Hg

0.1459 (0.0051, 0.2868)

0.04

0.0921 (0.0099, 0.1743)

0.03

<60 mm Hg

0 (ref)

0 (ref)

SBP
140+ mm Hg

0.0961 (-0.079, 0.2712)

0.28

0.2691 (0.1736, 0.3646)

<0.0001

120-140 mm Hg

0.1216 (0.0291, 0.2141)

0.01

0.1216 (0.0396, 0.2036)

0.004

<120 mm Hg
0 (ref)
0 (ref)
Visit 5
Abbreviations: ARIC-NCS, Atherosclerosis Risk in Communities Study Neurocognitive Study; DBP,
diastolic blood pressure; HDL-c, high density lipoprotein cholesterol; LDL-c, low density lipoprotein
cholesterol; MD, mean diffusivity; SBP, systolic blood pressure.
*Fully adjusted model including age, gender, education, race/center, BMI, the square of BMI, smoking status,
APOE E4, the other vascular risk factors, antihypertensive medication use, antidiabetic medication use, and
lipid-lowering medications.
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